Researchers speed identification of DNA regions that regulate gene expression

Credit: CC0 Public Domain

St. Jude Children's Research Hospital scientists have developed an integrated, high-throughput system to better understand and possibly manipulate gene expression for treatment of disorders such as sickle cell disease and beta thalassemia. The research appears today in the journal Nature Genetics.

Researchers used the system to identify dozens of DNA that act together to orchestrate the switch from fetal to adult hemoglobin expression. The method can also be used to study other diseases that involve .

Regulatory elements, also called genetic switches, are scattered throughout non-coding regions of DNA. These regions do not encode genes and make up about 98% of the genome. The elements have a variety of names—enhancer, repressor, insulator and more—but the they regulate, how the regulatory elements act together, and answers to other questions have been unclear.

"Without the high-throughput system, identifying key regulatory elements is often extremely slow," said corresponding author Yong Cheng, Ph.D., of the St. Jude Departments of Hematology and Computational Biology. Mitchell Weiss, M.D., Ph.D., Hematology chair, is co-corresponding author.

"For example, despite decades of research, fewer than half of regulatory elements and the associated genetic variants that account for fetal hemoglobin levels have been identified," Cheng said.

Precision editing provides key details about regulation of gene expression

The new system combines bioinformatic prediction algorithms and an adenine base editing tool with tests to measure how base gene editing affects . Base editing works more precisely than conventional gene-editing tools such as CRISPR/Cas9, by changing a single letter in the four-letter DNA alphabet at high efficiency without creating larger insertions or deletions.

Researchers used the base editor ABEmax to make 10,156 specific edits in 307 regulatory elements that were predicted to affect fetal hemoglobin expression. The expression can modify the severity of hemoglobin disorders such as sickle cell disease. The edits changed the DNA bases adenine and thymine to guanine and cytosine. The study focused on regulatory elements in the genes BCL11A, MYB-HBS1L, KLF1 and beta-like globin .

Using this approach, the scientists validated the few known regulatory elements of fetal hemoglobin expression and identified many new ones.

More information: Cheng, L., Li, Y., Qi, Q. et al. Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression. Nat Genet (2021).

Journal information: Nature Genetics
Citation: Researchers speed identification of DNA regions that regulate gene expression (2021, May 6) retrieved 17 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Base editors flex sights on sickle-cell disease


Feedback to editors